🔎 Trials Near Me

መነሻ › Metastatic Cancer › Tennessee › Nashville

በNashville፣ TN ለMetastatic Cancer የሚደረጉ ክሊኒካዊ ጥናቶች

ለMetastatic Cancer የሚደረጉ 70 ጥናቶች በNashville እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Avenzo Therapeutics Recruiting Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07193511

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sarah Cannon Research Institute, Nashville
  • Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT07562152

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Vanderbilt Breast Center at One Hundred Oaks, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05564377

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06270706

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
  • Tennessee Oncology PLLC, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI), Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT06234605

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI), Nashville
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06586957

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Henry-Joyce Cancer Clinic, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06943755

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Vanderbilt Breast Center at One Hundred Oaks, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT05803382

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Henry-Joyce Cancer Clinic, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07222800

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07277413

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Henry-Joyce Cancer Clinic, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06989437

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07612176

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • SCRI Oncology Partners, Nashville
  • Tennessee Oncology, PLLC-Elliston Place Plaza Medical Oncology &Hematology, Nashville
  • Tennessee Oncology, PLLC - Saint Thomas West, Nashville
  • እና 3 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07222566

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT05118789

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sarah Cannon Research Institute, Nashville
  • SCRI Oncology Partners, Nashville
  • Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sarah Cannon Research Institute SCRI, Nashville
  • Nashville General Hospital, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institue, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06128551

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Tennessee Oncology PLLC, Nashville
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07403721

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Tennessee Oncology, PLLC, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07629960

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT05267626

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
  • SCRI Oncology Partners, Nashville
  • Tennessee Oncology, PLLC- Elliston Place Plaza, Nashville
  • እና 11 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07227415

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06566079

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Clinical Study Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT07335497

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT06440005

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
  • SCRI Oncology Partners, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06561685

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Nashville
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07647328

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Tennessee Oncology, Nashville
  • USO - US Oncology Research Network, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06119581

NPX372, a B7-H7:CD3 Bispecific Antibody, in Selected Solid Tumor Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
እድሜ 19 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07563829

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Vanderbilt Breast Center at One Hundred Oaks, Nashville
  • Vanderbilt University/Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT06311214

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute - Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT07213830

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute-Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT04913285

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Vanderbilt-Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT06769698

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon and HCA Research Institute, Nashville
  • Tennessee Oncology, Nashville
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT05614739

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Research Site, Nashville
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ18 ኦገስ 2026 · NCT06792695

FOG-001 in Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05919264

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Vanderbilt University/Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT05691491

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁላይ 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ29 ጁላይ 2026 · NCT07044336

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Investigative Site #102, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁላይ 2026 · NCT06545942

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ጁላይ 2026 · NCT06657144

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sara Cannon Research Institute Tennessee, Nashville
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ጁላይ 2026 · NCT05533697

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Exelixis Clinical Site #3, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ጁን 2026 · NCT06952010

A Study of LY4175408 in Participants With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT07046923

CT-95 in Advanced Cancers Associated With Mesothelin Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Context Investigational Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT06756035

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Research Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT06917079

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon, Nashville
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT05384626

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ሜይ 2026 · NCT05431270

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሜይ 2026 · NCT05379985

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሜይ 2026 · NCT06828588

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ኤፕሪ 2026 · NCT07020221

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt Ingram Cancer Center (Henry-Joyce Cancer Clinic), Nashville
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኤፕሪ 2026 · NCT06581406

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2026 · NCT05948865

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ፌብሩ 2026 · NCT06521554

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT06778863

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ፌብሩ 2026 · NCT06127407

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Urology Associates PC, Nashville
እድሜ 18 እና ከዚያ በላይ · ወንዶች · የተሻሻለው በ4 ፌብሩ 2026 · NCT04729114

Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Vanderbilt-Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ዲሴም 2025 · NCT05270213

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ዲሴም 2025 · NCT06108050

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
እድሜ ከ18 እስከ 99 · ሁሉም ጾታዎች · የተሻሻለው በ3 ዲሴም 2025 · NCT07021898

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኖቬም 2025 · NCT07136181

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Nashville
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ጁላይ 2025 · NCT06415487

በሌሎች ከተሞች ለMetastatic Cancer የሚደረጉ ጥናቶች

በNashville ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።